Zobrazeno 1 - 8
of 8
pro vyhledávání: '"C Chai-Coetzer"'
Publikováno v:
SLEEP Advances. 3:A47-A47
Introduction With insufficient providers of insomnia care, alternative approaches to the delivery of insomnia treatments are being explored. Research has demonstrated that insomnia can be successfully managed by primary care nurses but patient attitu
Autor:
D Bensen-Boakes, A Osman, L Lack, P Catcheside, N Antic, S Smith, C Chai-Coetzer, A O'Grady, N Dunn, J Robinson, D McEvoy, A Sweetman
Publikováno v:
SLEEP Advances. 3:A37-A37
Introduction Cognitive behavioural therapy for insomnia (CBT-I) is the recommended treatment for insomnia and improves insomnia symptoms. However, CBT-I effects on sleep-wake state discrepancy have not previously been examined in a sample of individu
Autor:
M Graco, G Weber, D Joffe, K Saravanan, R Heriseanu, N Whitehead, K Alava-Bravo, C DelaCruz, S Sood, J Curran, E Kaumaitotoya, J Pryor, J Ross, C Chai-Coetzer, D Berlowitz
Publikováno v:
SLEEP Advances. 3:A46-A46
Introduction Sleep disordered breathing (SDB) is highly prevalent in tetraplegia, yet most remain undiagnosed and untreated for the disorder. We have described the care models of three international SCI rehabilitation centres that are independently d
Publikováno v:
SLEEP Advances. 3:A68-A68
Introduction Co-morbid insomnia and sleep apnoea (COMISA) is associated with poor health and reduced adherence to continuous positive airway pressure (CPAP) therapy in sleep clinic samples. However, health and treatment correlates of COMISA in commun
Publikováno v:
SLEEP Advances. 2:A53-A54
Background Obstructive sleep apnoea (OSA) is a significant public health problem with large health and economic burden. Despite the existence of effective treatment, undiagnosed OSA remains a challenge. The gold standard diagnostic tool is polysomnog
Autor:
Ronald McEvoy, Andrea N. Natsky, C Chai Coetzer, Billingsley Kaambwa, Andrew Vakulin, Robert J. Adams
Publikováno v:
SLEEP Advances. 2:A10-A10
Background The current health care system is challenged with a large and rising demand for obstructive sleep apnoea (OSA) services. A paradigm shift in OSA management is required to incorporate the preferences of diagnosed patients and individuals at
Publikováno v:
SLEEP Advances. 2:A59-A59
Background Long term NIV is established therapy for patients with chronic type 2 respiratory failure (T2RF) due to neuromuscular disorders and obesity hypoventilation syndrome (OHS) without significant OSA. There is emerging evidence that COPD patien
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.